Screener
Outlook Therapeutics, Inc. OTLK Q2 2026 earnings
Reported August 14, 2026 · Before market open
Revenue$9.0KMiss by $957.7K
EPS-$0.14Miss by $0.06
Revenue estimate$966.7K
EPS estimate-$0.08
Next report
Date not yet announcedVersus estimates
Revenue
Q2 2026$9.0KMiss by $957.7K
Q1 2026$128.0KMiss by $4.3MQ4 2025-$1.2MMiss by $4.4MQ3 2025-$91.8KMiss by $5.9MQ2 2025$1.5MMiss by $4.3MDiluted EPS
FAQ
- When did Outlook Therapeutics, Inc. report Q2 2026 earnings?
- Outlook Therapeutics, Inc. (OTLK) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Outlook Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Outlook Therapeutics, Inc. reported revenue of $9.0K and eps of $-0.14 for Q2 2026.
- Did Outlook Therapeutics, Inc. beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $966.7K by $957.7K. EPS missed the consensus estimate of $-0.08 by $0.06.
- How did Outlook Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 99.4% from $1.5M a year earlier and eps grew 68.2% from $-0.44.
- Where can I find Outlook Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-094848) and the 10-Q periodic report (0001104659-26-098415) directly on SEC EDGAR. The filing index links above go to sec.gov.
